ID

29055

Beskrivning

Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Nyckelord

Versioner (5)
  1. 2017-10-05 2017-10-05 -
  2. 2018-02-22 2018-02-22 -
  3. 2018-02-22 2018-02-22 -
  4. 2018-02-22 2018-02-22 -
  5. 2021-09-17 2021-09-17 -
Rättsinnehavare

gsk

Uppladdad den

22 februari 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Ropinirole Case Report Form GSK RRL100013

Engelsk

INVESTIGATIONAL PRODUCT

9 Formulär  
Investigational Product
Beskrivning

Investigational Product

Alias
UMLS CUI-1
C0304229
Planned timepoint
Beskrivning

Planned timepoint

Datatyp

integer

Alias
UMLS CUI [1]
C2348792
Blinded dose level
Beskrivning

Blinded dose level

Datatyp

integer

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0304229
Start Date
Beskrivning

Start Date

Datatyp

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
Stop Date
Beskrivning

Stop Date

Datatyp

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C0304229
IP Container No. 1
Beskrivning

IP Container No 1

Datatyp

text

Alias
UMLS CUI [1,1]
C0180098
UMLS CUI [1,2]
C0304229
IP Container No. 2
Beskrivning

IP Container No 2

Datatyp

text

Alias
UMLS CUI [1,1]
C0180098
UMLS CUI [1,2]
C0304229
Has the subject missed investigational product for >2 consecutive days
Beskrivning

Has the subject missed investigational product for >2 consecutive days

Datatyp

boolean

Alias
UMLS CUI [1]
C0457454
Average number of hours between early and late dose
Beskrivning

Average number of hours between early and late dose

Datatyp

text

Tillbaka till toppen

Similar models

INVESTIGATIONAL PRODUCT

9 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Investigational Product
C0304229 (UMLS CUI-1)
Item
Planned timepoint
integer
C2348792 (UMLS CUI [1])
Planned timepoint
Code List
Planned timepoint
CL Item
Baseline (1)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
Day 3 (2)
(Comment:en)
CL Item
Vital signs (3)
C0518766 (UMLS CUI-1)
(Comment:en)
Blinded dose level
Item
Blinded dose level
integer
C0178602 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
IP Container No 1
Item
IP Container No. 1
text
C0180098 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
IP Container No 2
Item
IP Container No. 2
text
C0180098 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Has the subject missed investigational product for >2 consecutive days
Item
Has the subject missed investigational product for >2 consecutive days
boolean
C0457454 (UMLS CUI [1])
Average number of hours between early and late dose
Item
Average number of hours between early and late dose
text
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial